Cargando…
Intravitreal Clindamycin as First-Line Therapy for Toxoplasmic Retinochoroiditis: A Case Series
PURPOSE: To report a case series of four ocular toxoplasmosis patients who received intravitreal clindamycin as first-line treatment. MATERIALS AND METHODS: Retrospective interventional case series. RESULTS: Four (two females and two males) patients were diagnosed with active primary toxoplasmic ret...
Autores principales: | Verma, Lalit, Thulasidas, Mithun, Gupta, Avnindra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733341/ https://www.ncbi.nlm.nih.gov/pubmed/33324033 http://dx.doi.org/10.2147/OPTH.S288725 |
Ejemplares similares
-
Intravitreal Clindamycin in the Treatment of Unresponsive Zone One Toxoplasmic Chorioretinitis: A Case Report
por: Hosseini, Seyedeh Maryam, et al.
Publicado: (2014) -
Design and development of intraocular polymeric implant systems for long-term controlled-release of clindamycin phosphate for toxoplasmic retinochoroiditis
por: Tamaddon, Lana, et al.
Publicado: (2015) -
Kyrieleis arteritis associated with toxoplasmic retinochoroiditis: A case report
por: Mahjoub, Ahmed, et al.
Publicado: (2022) -
Interleukin-1 gene polymorphisms and toxoplasmic retinochoroiditis
por: Cordeiro, Cynthia A., et al.
Publicado: (2008) -
Is reactivation of toxoplasmic retinochoroiditis associated to increased annual rainfall?
por: Rudzinski, Marcelo, et al.
Publicado: (2013)